Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate. Issue 10 (15th August 2017)

• Record Type: Journal Article
• Authors: Napolitano, Mariasanta; Santoro, Marco; Mancuso, Salvatrice; Carlisi, Melania; Raso, Simona; Tarantino, Giuseppe; Accurso, Vincenzo; Siragusa, Sergio
• Is Part Of: Clinical case reports. Volume 5:Issue 10(2017)
• Page Start: 1573
• Page End: 1575
• Publication Date: 2017-08-15
• Subjects: Adverse events -- chronic myeloid leukemia -- imatinib -- optic disk edema -- optic nerve edema -- tyrosine kinase inhibitors; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.1137
• Languages: English
• ISSNs: 2050-0904

Abstract

Key Clinical Message: Prompt ophthalmology evaluation and immediate imatinib suspension should be suggested at any time of tyrosine kinase inhibitor therapy in patients with visual deficit, as it may be a clinical manifestation of optic disk edema, and suspension may help in prompt recovery. Abstract : Prompt ophthalmology evaluation and immediate imatinib suspension should be suggested at any time of tyrosine kinase inhibitor therapy in patients with visual deficit, as it may be a clinical manifestation of optic disk edema, and suspension may help in prompt recovery.